Can-Fite BioPharma Ltd. CANF
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.04M | 7.04M | 8.54M | 8.54M | 6.46M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 960.00K | 960.00K | 826.00K | 826.00K | 1.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 74.00K | 74.00K | -- |
| Total Current Assets | 8.00M | 8.00M | 9.44M | 9.44M | 7.62M |
|
|
|||||
| Total Current Assets | 8.00M | 8.00M | 9.44M | 9.44M | 7.62M |
| Net Property, Plant & Equipment | 52.00K | 52.00K | 74.00K | 74.00K | 96.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 8.06M | 8.06M | 9.51M | 9.51M | 7.72M |
|
|
|||||
| Total Accounts Payable | 681.00K | 681.00K | 1.16M | 1.16M | 1.15M |
| Total Accrued Expenses | 1.09M | 1.09M | 1.11M | 1.11M | 506.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 48.00K | 48.00K | 56.00K | 56.00K | 57.00K |
| Total Finance Division Other Current Liabilities | 405.00K | 405.00K | 405.00K | 405.00K | 405.00K |
| Total Other Current Liabilities | 405.00K | 405.00K | 405.00K | 405.00K | 405.00K |
| Total Current Liabilities | 2.23M | 2.23M | 2.73M | 2.73M | 2.12M |
|
|
|||||
| Total Current Liabilities | 2.23M | 2.23M | 2.73M | 2.73M | 2.12M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.00K | 1.00K | 15.00K | 15.00K | 33.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 974.00K | 974.00K | 1.18M | 1.18M | 1.38M |
| Total Liabilities | 3.20M | 3.20M | 3.92M | 3.92M | 3.54M |
|
|
|||||
| Common Stock & APIC | 184.52M | 184.52M | 180.65M | 180.65M | 174.29M |
| Retained Earnings | -180.79M | -180.79M | -176.19M | -176.19M | -171.24M |
| Treasury Stock & Other | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M |
| Total Common Equity | 4.86M | 4.86M | 5.59M | 5.59M | 4.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.86M | 4.86M | 5.59M | 5.59M | 4.18M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.86M | 4.86M | 5.59M | 5.59M | 4.18M |
|
|
|||||